Loading...
Market
Novo Nordisk stock price changes by end of 2024
4
Resolution / Starting Odds
Stock price increases by more than 20% • 25%
Stock price increases by 10-20% • 25%
Stock price increases by less than 10% • 25%
Stock price decreases • 25%
Stock market data and financial news outlets
Story
Novo Nordisk's Ozempic Reduces Death Risk by 20% in FLOW Trial
May 24, 2024, 11:23 AM
Novo Nordisk's diabetes drug Ozempic has shown significant benefits in a recent trial involving patients with type 2 diabetes and chronic kidney disease. The study, known as the FLOW trial, revealed that Ozempic cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Additionally, the drug significantly reduced the risk of major kidney disease events and slowed the progression of diabetic kidney disease. Over a three-year period, treating 39 patients with Ozempic would prevent one death. These findings highlight Ozempic's potential to transform treatment for patients suffering from these conditions.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
10-20% increase • 25%
21-50% increase • 25%
51-100% increase • 25%
more than 100% increase • 25%
Profit decline over 20% • 25%
Profit decline 10-20% • 25%
Profit decline less than 10% • 25%
No significant change or profit increase • 25%
<20% • 25%
20%-40% • 25%
40%-60% • 25%
>60% • 25%
Significant Increase (>15%) • 33%
Moderate Increase (5-15%) • 33%
Little to No Change (<5%) • 33%
Increase over 200% • 25%
Increase 100-200% • 25%
Increase up to 100% • 25%
Decrease or no change • 25%
Increase more than 20% • 25%
Increase 10-20% • 25%
Decrease or no change • 25%
Decrease more than 20% • 25%
<$5 billion • 25%
$5 billion to $10 billion • 25%
$10 billion to $15 billion • 25%
>$15 billion • 25%
Increase more than 10% • 25%
Increase less than 10% • 25%
Decrease less than 10% • 25%
Decrease more than 10% • 25%
20% increase or more • 25%
10-20% increase • 25%
0-10% increase • 25%
No increase or decrease • 25%
Increased > 20% • 33%
Decreased > 20% • 33%
Changed < 20% • 33%